Nutraferon CT-PRIDE P Capsules

Reflux and severe indigestion involve both chemical irritation (excess acid) and mechanical stasis (slow stomach emptying and a relaxed lower esophageal sphincter). Pantoprazole shuts down acid production, while Cinitapride tightens the esophageal valve and moves food downward into the intestine.

Pantoprazole requires meal-triggered activation of parietal cell proton pumps to bind effectively, and taking the capsule 30 to 60 minutes before breakfast aligns peak drug absorption with mealtime pump recruitment while allowing Cinitapride to prime gastric motility.

Standard CT-PRIDE 1 mg tablets are immediate-release and taken three times a day (totaling 3 mg/day). Nutraferon CT-PRIDE-P encapsulates the entire 3 mg daily dose into an Extended-Release (SR/ER) pellet matrix that releases Cinitapride gradually over 24 hours from a single morning capsule.

Cinitapride begins improving gastric emptying from the first day, while Pantoprazole achieves maximal steady-state acid inhibition after 2 to 3 days of daily dosing. Full mucosal healing in erosive esophagitis typically takes 4 to 8 weeks.

If breakthrough heartburn occurs during the first few days of therapy, rescue antacids may be used if approved by your doctor, but they should be spaced at least 1 to 2 hours apart from Nutraferon CT-PRIDE-P so they do not prematurely alter the enteric-coated pH dissolution profile.